Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
GNNSF
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
finance.yahoo.comPOSITIVO
GenScript Launches Life Sciences Startup PitchFest with NVIDIA to Accelerate Biotech Innovation
Inaugural competition will connect emerging AI life sciences platforms with validation expertise, investors, and ecosystem partners during JPM Week PISCATAWAY, N.J. and SANTA CLARA, Calif., Oct. 8, 2026 /PRNewswire/ -- GenScript Biotech Co…
What's next for personalized mRNA cancer vaccines?
[mrna Cancer Vaccine] wildpixel/iStock via Getty Images INVESTORS SHOULD KNOW: Personalized mRNA cancer vaccines are moving beyond their first major clinical success in melanoma into a broader test across harder-to-treat solid tumors. The…
Recombinant Proteins Market - Global Strategic Business Report: Sales Hit to $5.8 Billion by 2030 - Benchmark Thermo Fisher Scientific, Merck KGaA, Amgen, Bio-Techne and GenScript Biotech Amid Tariff Disruption
Company Logo Demand for biologics, targeted therapies and personalized medicine is rising, while AI-led protein design and scalable bioprocessing unlock new opportunities. Dublin, Sept. 30, 2026 (GLOBE NEWSWIRE) -- "Recombinant Proteins Ma…
Global DNA Manufacturing Market Size, Share, Trends, and Forecast, 2026-2033 | Market to Reach $23.1 Billion as Gene Therapy and Synthetic Biology Drive 17.8% CAGR
Company Logo Capitalize on gene therapy and vaccine demand through automated, scalable DNA synthesis and actionable segment, regional, and competitive insights. Dublin, Sept. 29, 2026 (GLOBE NEWSWIRE) -- "DNA Manufacturing Market Size, Sha…
Beyond GLP-1 injectables, who wins the next phase for obesity drugs?
[Ozempic Insulin injection pen] CR/iStock via Getty Images INVESTORS SHOULD KNOW: The obesity drug market is undergoing a structural shift, moving beyond the initial injectable GLP-1 franchise. Now, the industry is moving toward a broader…
ProBio and Kun Tuo Announce Strategic Collaboration to Deliver Integrated CDMO-CRO Solutions for Advanced Therapies
Partnership combines manufacturing, development and clinical operations expertise to accelerate Investigator-Initiated Trials and clinical execution in China HOPEWELL, N.J., Aug. 16, 2026 /PRNewswire/ -- ProBio, a leading global contract d…
Biotech Breakout: What's in focus after Moderna's cancer win?
[mRNA or messenger RNA. The concept of mRNA vaccine. Innovative methods to treat virus. 3d render] Krot Studio INVESTORS SHOULD KNOW: A major Phase 3 trial win from Moderna (MRNA [https://seekingalpha.com/symbol/MRNA]) and Merck (MRK [http…
This article first appeared on GuruFocus. Revenue: Total revenue reached $404.2 million, up 27.3% year-over-year. Adjusted Net Profit: Reached $62.5 million, up 203.3% year-over-year. Gross Profit: Group gross profit reached $206.7 million…
GenScript and Tamarind Bio Partner to Connect AI Molecular Design with Rapid Lab Validation
Collaboration combines Tamarind Bio's AI-powered molecular design platform with GenScript's wet-lab capabilities to help researchers move from digital concepts to experimental proof PISCATAWAY, N.J. and SAN FRANCISCO, Aug. 5, 2026 /PRNewsw…
Genscript Biotech (SEHK:1548) Valuation Check After Recent Share Price Pullback
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Recent price moves and business snapshot Genscript Biotech (SEHK:1548) has seen the stock slip abou…
DNA Synthesis Market to Reach $30.4 billion, Globally, by 2035 at 18.2% CAGR: Allied Market Research
The DNA synthesis market is witnessing strong adoption across pharmaceutical and biotechnology companies, academic and research institutes, contract research organizations (CROs), and synthetic biology firms due to its critical role in ena…
GenScript Sets New Benchmark for Responsible Biotech Leadership with 2025 ESG Report
Advancing Climate Action, Governance Excellence, and Global Scientific Impact PISCATAWAY, N.J., April 14, 2026 /PRNewswire/ -- GenScript Biotech Corporation today announced its 2025 Environmental, Social, and Governance (ESG) Report, posit…
GenScript and Mimulus Partner to Industrialize DNA-Based Data Storage for the AI Era
The multi-year collaboration aims to scale molecular data storage infrastructure and unlock breakthrough cost efficiencies by 2030. PISCATAWAY, N.J. and LOS ANGELES, April 9, 2026 /PRNewswire/ -- GenScript Biotech Corporation, the world's…
GenScript and Mimulus Partner to Industrialize DNA-Based Data Storage for the AI Era
The multi-year collaboration aims to scale molecular data storage infrastructure and unlock breakthrough cost efficiencies by 2030. PISCATAWAY, N.J. and LOS ANGELES, April 9, 2026 /PRNewswire/ -- GenScript Biotech Corporation, the world's…
Genscript Biotech Corp (GNNSF) Full Year 2025 Earnings Call Highlights: Record Revenue Growth ...
This article first appeared on GuruFocus. Group Revenue: Increased by 61.4% year over year to $959.5 million. Adjusted Net Profit: Reached nearly $230 million. Life Science Group Revenue: Grew 14.8% year over year to $522.1 million. ProBio…
Assessing Genscript Biotech (SEHK:1548) Valuation After Recent Share Price Volatility
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Why Genscript Biotech is on investors’ radar Genscript Biotech (SEHK:1548) has drawn fresh attention after recent share pric…
GenScript Biotech Global Forum, "Scripting Possibilities", Convened AI and Biopharma Leaders in San Francisco
Panel discussions brought to life important insights into how AI could change the face of biopharma drug discovery in 2026 and beyond PISCATAWAY, N.J., Jan. 29, 2026 /PRNewswire/ -- GenScript Biotech Corporation, a global leader in life sc…
GenScript is Scripting Possibilities in AI-Driven Drug Discovery as Wet-Lab Partner for Latent-X2 Innovation
PISCATAWAY, N.J., Jan. 28, 2026 /PRNewswire/ -- GenScript Biotech Corporation, a global leader in life science research and biotech solutions, today announced its supporting role in the experimental validation of Latent-X2 — further provin…
'Scripting Possibilities' in Biotechnology: Global Innovators Converge in San Francisco for GenScript's 5th Annual Biotech Forum During JPM Week
PISCATAWAY, N.J., Jan. 6, 2026 /PRNewswire/ -- GenScript Biotech Corporation, a global leader in life sciences R&D and manufacturing services, is proud to announce its 5th Annual Biotech Global Forum, scheduled for January 14, 2026, at the…
'Scripting Possibilities' in Biotechnology: Global Innovators Converge in San Francisco for GenScript's 5th Annual Biotech Forum During JPM Week
PISCATAWAY, N.J., Jan. 6, 2026 /PRNewswire/ -- GenScript Biotech Corporation, a global leader in life sciences R&D and manufacturing services, is proud to announce its 5th Annual Biotech Global Forum, scheduled for January 14, 2026, at the…
Exploring the Next Era of CGT and Unlocking Limitless Possibilities: The GenScript Biotech Global Forum London 2025 Wraps Up
PISCATAWAY, N.J., Nov. 22, 2025 /PRNewswire/ -- GenScript Biotech Corporation, a global leader in life sciences R&D and manufacturing services, successfully hosted the GenScript Biotech Global Forum London 2025 in the UK. This marks the Fo…
3 Asian Stocks That Could Be Trading Below Their True Value In August 2025
As Asian markets navigate the complexities of global trade tensions and economic slowdowns, investors are increasingly focused on identifying opportunities that may be trading below their intrinsic value. In this environment, a good stock…
GenScript Biotech Demonstrates Profitable Scale and Strategic Leadership in H1 2025, Establishing Clear Industry Leadership Through Accelerated Growth and Innovation
Rising Global Footprint, Best-in-Class Innovation, and ESG Excellence Set Stage for Sustained Value Creation PISCATAWAY, N.J., Aug. 17, 2025 /PRNewswire/ -- GenScript Biotech Corporation (HK.1548), a global pioneer in life sciences innovat…
GenScript Unveils New Global Identity: "Scripting Possibilities" to Power the Future of Biotechnology
PISCATAWAY, N.J., Aug. 8, 2025 /PRNewswire/ -- GenScript Biotech Corporation (HK.1548), a global leader in life sciences innovation, today unveiled its new global brand platform: Scripting Possibilities—a future-forward identity designed t…
Cell Line Development Market Outlook Report 2025-2034: PromoCell, Novartis, Genscript Biotech, Sartorius, and Thermo Fisher Scientific Dominate the Industry
Company Logo Booming Biologics and Biosimilars Market Drives Global Cell Line Development Surge; CDMOs and Technological Advancements Key to Growth Cell Line Development MarketCell Line Development Market Dublin, Aug. 06, 2025 (GLOBE NEWSW…
GenScript Biotech's MSCI ESG Rating Upgraded to AA, Recognized as a Global Leader
PISCATAWAY, N.J., July 31, 2025 /PRNewswire/ -- GenScript Biotech Corporation (HK.1548), a leading global provider of life science research and manufacturing services, today announced that its ESG rating has been upgraded to AA from A by M…
GenScript Biotech Earns EcoVadis Silver Medal, Ranking in Top 15% Globally for Sustainability
PISCATAWAY, N.J., July 9, 2025 /PRNewswire/ -- GenScript Biotech Corporation (HK.1548), a leading global provider of life science research and manufacturing services, today announced that it has been awarded a Silver Medal by EcoVadis, a g…
Asian Market Insights: 3 Stocks That Investors Might Be Undervaluing
As global markets respond to easing trade tensions and positive economic signals, Asian indices have shown resilience, with notable gains in China and Japan. In this environment, identifying undervalued stocks becomes crucial for investors…
ProBio Opens Flagship U.S. Plasmid & Viral Vector Manufacturing Facility in Hopewell, New Jersey to Advance Cell and Gene Therapy
HOPEWELL, N.J., June 27, 2025 /PRNewswire/ -- ProBio, a global contract development and manufacturing organization (CDMO) specializing in cell and gene therapy, today announced the opening of its flagship Cell and Gene Therapy Center of Ex…
As the Asian markets respond positively to a temporary de-escalation in U.S.-China trade tensions, investors are closely watching for opportunities that may arise from this newfound stability. In such an environment, identifying stocks tra…
Asian Stocks Estimated Below Intrinsic Value In April 2025
As global markets navigate a complex landscape marked by trade tensions and monetary policy shifts, Asian indices are showing resilience, with Chinese stocks experiencing gains amid expectations of increased stimulus. In this environment,…
ProBio Sets New Standard in GMP Plasmid DNA Manufacturing with Guaranteed ≥ 85% Supercoiled DNA, Fixed-Cost, Clinical-Grade Delivered in Just 3 Months
Hopewell-based team delivers on ProBio's promise of speed, quality, and reliability—offering a transparent, fixed-cost model and ≥85% supercoiled plasmid DNA in record time for clinical programs. HOPEWELL, N.J., April 9, 2025 /PRNewswire/…
Asian Market Insights: 3 Stocks Estimated Below Intrinsic Value
As global markets grapple with inflation concerns and trade uncertainties, the Asian market presents a unique landscape where opportunities for investment can still be found. In this environment, identifying stocks that are potentially und…
Strategic deconsolidation of Legend Biotech unlocked significant value, while core businesses experienced rapid growth. PISCATAWAY, N.J., March 12, 2025 /PRNewswire/ -- GenScript Biotech Corporation (HKEX: 1548.HK), a leading global techno…